These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 22004944)
61. Impact of metabolic syndrome on ischemic heart disease - a prospective cohort study in an Iranian adult population: Isfahan Cohort Study. Talaei M; Sadeghi M; Marshall T; Thomas GN; Kabiri P; Hoseini S; Sarrafzadegan N Nutr Metab Cardiovasc Dis; 2012 May; 22(5):434-41. PubMed ID: 21195593 [TBL] [Abstract][Full Text] [Related]
62. Effects of short-term exposure to air pollution on hospital admissions of young children for acute lower respiratory infections in Ho Chi Minh City, Vietnam. ; Le TG; Ngo L; Mehta S; Do VD; Thach TQ; Vu XD; Nguyen DT; Cohen A Res Rep Health Eff Inst; 2012 Jun; (169):5-72; discussion 73-83. PubMed ID: 22849236 [TBL] [Abstract][Full Text] [Related]
63. De novo sensitization during subcutaneous allergen specific immunotherapy - an analysis of 51 cases of SCIT and 33 symptomatically treated controls. Gellrich D; Eder K; Högerle C; Becker S; Canis M; Gröger M Sci Rep; 2020 Apr; 10(1):6048. PubMed ID: 32269269 [TBL] [Abstract][Full Text] [Related]
64. Trends in mortality, incidence and case fatality of ischaemic heart disease in Denmark, 1982-1992. Osler M; Sørensen TI; Sørensen S; Rostgaard K; Jensen G; Iversen L; Kristensen TS; Madsen M Int J Epidemiol; 1996 Dec; 25(6):1154-61. PubMed ID: 9027519 [TBL] [Abstract][Full Text] [Related]
65. Correlation between relative rates of hospital treatment or death due to ischaemic heart disease (IHD) and of IHD-related medication among socio-occupational and economic activities groups in Denmark, 1996-2005. Hannerz H; Dalhoff K; Burr H; Latza U Int J Occup Med Environ Health; 2014 Aug; 27(4):536-46. PubMed ID: 25008851 [TBL] [Abstract][Full Text] [Related]
66. Factors affecting time required to reach maintenance dose during subcutaneous immunotherapy. Jourdy DN; Reisacher WR Int Forum Allergy Rhinol; 2012; 2(4):294-9. PubMed ID: 22434700 [TBL] [Abstract][Full Text] [Related]
67. [Causes of stopping subcutaneous specific immunotherapy in asthmatic children]. Huang YN; Huang Y; Dai JH; Yang FF Zhongguo Dang Dai Er Ke Za Zhi; 2012 Sep; 14(9):671-4. PubMed ID: 22989436 [TBL] [Abstract][Full Text] [Related]
68. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions. Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI J Allergy Clin Immunol Pract; 2014; 2(2):161-7. PubMed ID: 24607043 [TBL] [Abstract][Full Text] [Related]
69. Risk stratification of systemic reactions to subcutaneous immunotherapy: A retrospective study. Sani S; Gupta R; Fonacier L; Aquino M Allergy Asthma Proc; 2019 Sep; 40(5):338-342. PubMed ID: 31514792 [No Abstract] [Full Text] [Related]
70. Allergen-specific immunotherapy and risk of autoimmune disease. Linneberg A; Madsen F; Skaaby T Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):635-9. PubMed ID: 22914311 [TBL] [Abstract][Full Text] [Related]
71. Side effects during subcutaneous immunotherapy in children with allergic diseases. Tophof MA; Hermanns A; Adelt T; Eberle P; Gronke C; Friedrichs F; Knecht R; Mönter E; Schöpfer H; Schwerk N; Steinbach J; Umpfenbach HU; Weißhaar C; Wilmsmeyer B; Bufe A Pediatr Allergy Immunol; 2018 May; 29(3):267-274. PubMed ID: 29247543 [TBL] [Abstract][Full Text] [Related]
72. The association of atopy with incidence of ischemic heart disease, stroke, and diabetes. Skaaby T; Husemoen LL; Thuesen BH; Jeppesen J; Linneberg A Endocrine; 2015 Mar; 48(2):541-50. PubMed ID: 24917447 [TBL] [Abstract][Full Text] [Related]
73. Quality assurance ofallergen-specific immunotherapy during a national outbreak of anaphylaxis: results of a continuous sentinel event surveillance system. Madsen F; Frølund L; Christensen M; Frost A; Petersen US J Investig Allergol Clin Immunol; 2009; 19(4):253-9. PubMed ID: 19639720 [TBL] [Abstract][Full Text] [Related]
74. Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease. Skaaby T; Husemoen LL; Thuesen BH; Linneberg A Endocrine; 2015 Sep; 50(1):231-8. PubMed ID: 25666936 [TBL] [Abstract][Full Text] [Related]
75. Depression and the risk of autoimmune disease: a nationally representative, prospective longitudinal study. Andersson NW; Gustafsson LN; Okkels N; Taha F; Cole SW; Munk-Jørgensen P; Goodwin RD Psychol Med; 2015 Dec; 45(16):3559-69. PubMed ID: 26271451 [TBL] [Abstract][Full Text] [Related]
77. [Specific allergen immunotherapy in autoimmune diseases]. Bożek A Przegl Lek; 2015; 72(12):770-2. PubMed ID: 27024958 [TBL] [Abstract][Full Text] [Related]
78. Impact of quality improvement measures on the delivery of allergy immunotherapy: a 2-year follow-up. Mattos JL; Ferguson BJ; Lee S Int Forum Allergy Rhinol; 2015 Jun; 5(6):513-6. PubMed ID: 25845709 [TBL] [Abstract][Full Text] [Related]
79. Diagnosis and treatment of allergic diseases in Zhejiang Province: a cross-sectional survey. Wang HY; Shen YH; Yang XY; Tang LF; Zhou JY; J Zhejiang Univ Sci B; 2015 Jul; 16(7):640-50. PubMed ID: 26160722 [TBL] [Abstract][Full Text] [Related]
80. Efficacy of epinephrine and diphenhydramine rinses in decreasing local reactions to subcutaneous aeroallergen immunotherapy. Mustafa SS; Vadamalai K; Bingemann T; Ramsey A Allergy Asthma Proc; 2020 Jan; 41(1):52-58. PubMed ID: 31888783 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]